Biotronik Launches Passeo-18 Lux Drug-Releasing Balloon in Europe
Published date : 22 January 2014
Article date : 02 November 2014
Biotronik announced the release of its Passeo-18 Lux drug-releasing balloon (DRB) in all countries recognizing CE Mark. The device recently earned European CE Mark approval.
The company stated that the Passeo-18 Lux is a novel combination device for treating de novo and restenotic femoropopliteal lesions. The device’s design is based on the company’s Passeo-18 percutaneous transluminal angioplasty (PTA) catheter, which is coated with a matrix of antiproliferative paclitaxel and a biocompatible excipient that enables an optimal drug transfer to the target lesion tissue. The Passeo-18 Lux includes a novel protective insertion aid to facilitate easier device introduction and handling.